Found 87 results
[ Author(Desc)] Title Type Year
Filters: Author is Luiz E Bermudez  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
B
L. E. Bermudez and Petrofsky, M., Regulation of the expression of Mycobacterium avium complex proteins differs according to the environment within host cells., Immunology and cell biology, vol. 75, no. 1, pp. 35-40, 1997.
L. E. Bermudez, Infection of "nonprofessional phagocytes" with Mycobacterium avium complex., Clinical immunology and immunopathology, vol. 61, no. 2 Pt 1, pp. 225-35, 1991.
L. E. Bermudez, Shelton, K., and Young, L. S., Comparison of the ability of Mycobacterium avium, M. smegmatis and M. tuberculosis to invade and replicate within HEp-2 epithelial cells., Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, vol. 76, no. 3, pp. 240-7, 1995.
L. E. Bermudez and Young, L. S., Recombinant granulocyte-macrophage colony-stimulating factor activates human macrophages to inhibit growth or kill Mycobacterium avium complex., Journal of leukocyte biology, vol. 48, no. 1, pp. 67-73, 1990.
L. E. Bermudez, Kolonoski, P., Seitz, L. E., Petrofsky, M., Reynolds, R., Wu, M., and Young, L. S., SRI-286, a thiosemicarbazole, in combination with mefloquine and moxifloxacin for treatment of murine Mycobacterium avium complex disease., Antimicrobial agents and chemotherapy, vol. 48, no. 9, pp. 3556-8, 2004.
L. E. Bermudez, Kolonoski, P., Young, L. S., and Inderlied, C. B., Activity of KRM 1648 alone or in combination with ethambutol or clarithromycin against Mycobacterium avium in beige mouse model of disseminated infection., Antimicrobial agents and chemotherapy, vol. 38, no. 8, pp. 1844-8, 1994.
L. E. Bermudez, Wu, M., and Young, L. S., Intracellular killing of Mycobacterium avium complex by rifapentine and liposome-encapsulated amikacin., The Journal of infectious diseases, vol. 156, no. 3, pp. 510-3, 1987.
L. E. Bermudez, Nash, K., Petrofsky, M., Young, L. S., and Inderlied, C. B., Clarithromycin-resistant mycobacterium avium is still susceptible to treatment with clarithromycin and is virulent in mice., Antimicrobial agents and chemotherapy, vol. 44, no. 10, pp. 2619-22, 2000.
L. E. Bermudez, Petrofsky, M., Wu, M., and Young, L. S., Clarithromycin significantly improves interleukin-12-mediated anti-Mycobacterium avium activity and abolishes toxicity in mice., The Journal of infectious diseases, vol. 178, no. 3, pp. 896-9, 1998.
L. E. Bermudez, Wu, M., Petrofsky, M., and Young, L. S., Interleukin-6 antagonizes tumor necrosis factor-mediated mycobacteriostatic and mycobactericidal activities in macrophages., Infection and immunity, vol. 60, no. 10, pp. 4245-52, 1992.
L. E. Bermudez, Danelishvili, L., and Early, J., Mycobacteria and Macrophage Apoptosis: Complex Struggle for Survival., Microbe Wash DC, vol. 1, no. 8, pp. 372-375, 2006.
L. E. Bermudez, Petrofsky, M., and Shelton, K., Epidermal growth factor-binding protein in Mycobacterium avium and Mycobacterium tuberculosis: a possible role in the mechanism of infection., Infection and immunity, vol. 64, no. 8, pp. 2917-22, 1996.
L. E. Bermudez, Inderlied, C., and Young, L. S., Stimulation with cytokines enhances penetration of azithromycin into human macrophages., Antimicrobial agents and chemotherapy, vol. 35, no. 12, pp. 2625-9, 1991.
L. E. Bermudez and Young, L. S., Factors affecting invasion of HT-29 and HEp-2 epithelial cells by organisms of the Mycobacterium avium complex., Infection and immunity, vol. 62, no. 5, pp. 2021-6, 1994.
L. E. Bermudez and Young, L. S., Oxidative and non-oxidative intracellular killing of Mycobacterium avium complex., Microbial pathogenesis, vol. 7, no. 4, pp. 289-98, 1989.
L. E. Bermudez, Reynolds, R., Kolonoski, P., Aralar, P., Inderlied, C. B., and Young, L. S., Thiosemicarbazole (thiacetazone-like) compound with activity against Mycobacterium avium in mice., Antimicrobial agents and chemotherapy, vol. 47, no. 8, pp. 2685-7, 2003.
L. E. Bermudez, Covaro, G., and Remington, J., Infection of murine macrophages with Toxoplasma gondii is associated with release of transforming growth factor beta and downregulation of expression of tumor necrosis factor receptors., Infection and immunity, vol. 61, no. 10, pp. 4126-30, 1993.
L. E. Bermudez, [Bacteremias in immunosuppressed patients]., Revista paulista de medicina, vol. 104, no. 2, pp. 87-92, 1986.
L. E. Bermudez, Goodman, J., and Petrofsky, M., Role of complement receptors in uptake of Mycobacterium avium by macrophages in vivo: evidence from studies using CD18-deficient mice., Infection and immunity, vol. 67, no. 9, pp. 4912-6, 1999.
L. E. Bermudez, Parker, A., and Goodman, J. R., Growth within macrophages increases the efficiency of Mycobacterium avium in invading other macrophages by a complement receptor-independent pathway., Infection and immunity, vol. 65, no. 5, pp. 1916-25, 1997.
L. E. Bermudez, Wu, M., Martinelli, J., and Young, L. S., Ethanol affects release of TNF and GM-CSF and membrane expression of TNF receptors by human macrophages., Lymphokine and cytokine research, vol. 10, no. 5, pp. 413-9, 1991.
L. E. Bermudez, Wu, M., and Young, L. S., Interleukin-12-stimulated natural killer cells can activate human macrophages to inhibit growth of Mycobacterium avium., Infection and immunity, vol. 63, no. 10, pp. 4099-104, 1995.
L. E. Bermudez, Martinelli, J. C., Gascon, R., Wu, M., and Young, L. S., Protection against gram-negative bacteremia in neutropenic mice with recombinant granulocyte-macrophage colony-stimulating factor., Cytokine, vol. 2, no. 4, pp. 287-93, 1990.
L. E. Bermudez, Motamedi, N., Chee, C., Baimukanova, G., Kolonoski, P., Inderlied, C., Aralar, P., Wang, G., Phan, L. Tam, and Young, L. S., EDP-420, a bicyclolide (bridged bicyclic macrolide), is active against Mycobacterium avium., Antimicrobial agents and chemotherapy, vol. 51, no. 5, pp. 1666-70, 2007.
L. E. Bermudez, Inderlied, C. B., Kolonoski, P., Petrofsky, M., and Young, L. S., Clarithromycin, dapsone, and a combination of both used to treat or prevent disseminated Mycobacterium avium infection in beige mice., Antimicrobial agents and chemotherapy, vol. 38, no. 12, pp. 2717-21, 1994.

Pages